Ataxia
Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
Subtype terms (2)
More specific conditions that are subtypes of Ataxia in the MeSH hierarchy.
- Cerebellar Ataxia
8 drugs (2 approved, 6 experimental)
- Gait Ataxia
Drugs by status
Phase 4 trials (1)
Phase 3 trials (1)
Phase 2 trials (5)
Phase 1 trials (1)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (8)
Organization Involved with Phase 3 Indications (22)
- Horizon Pharma
- Santhera
- Pfizer
- Cognitive Research Corporation
- Erydel
- PTC Therapeutics
- Retrotope, Inc.
- National Institutes of Health (NIH)
- University of Roma La Sapienza
- University of Pennsylvania
- University of London
- Federal University of Rio Grande do Sul
- University of South Florida
- University of California, Los Angeles
- University of California, San Francisco
- National Taiwan University
- University of Paris
- Agenzia Italiana del Farmaco
- Biohaven Pharmaceuticals Inc.
- Cytel Inc.
- Friedreich's Ataxia Research Alliance (FARA)
- Assistance Publique - Hôpitaux de Paris
Organization Involved with Phase 2 Indications (47)
- AbbVie
- Vidara Therapeutics
- Takeda
- Apotex
- Ipsen
- Baxalta
- Bioelectron
- Penwest Pharmaceuticals Co.
- Reata Pharmaceuticals, Inc.
- Sclnow Biotechnology Co., Ltd.
- Steminent Biotherapeutics Inc.
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- National Institute of Neurological Disorders and Stroke (NINDS)
- Central South University
- IRCCS Eugenio Medea
- McMaster University
- Nanjing Medical University
- Nanjing University
- National Yang-Ming University
- Radboud University
- RWTH Aachen University
- Seoul National University
- University of Melbourne
- University of Rochester
- University of Rome Tor Vergata
- Xuzhou Medical University
- Mayo Clinic
- University of California, Davis
- University of Naples Frederico II
- University of Queensland
- +17 more
Organization Involved with Phase 1 Indications (11)
Organization Involved with Other Experimental Indications (8)